The awkward ingredient

St. John’s Wort In A Nighttime Capsule

It turns up on sleep and calm labels regularly, its own evidence base is for something else entirely, and it carries the best-documented set of drug interactions of any herb on a supermarket shelf. This is the article that costs the product beside it the most, and it is the one worth reading first.

By Serenity Prime Team · Last updated September 19, 2026 · 9 min read · The awkward ingredient

Why it appears on a sleep label at all

St. John’s wort is not a sleep herb. Its human research is about depressive symptoms, and that is where the systematic reviews sit.

The reason it turns up in nighttime formulas is that low mood and poor sleep travel together, and a formulator putting together a calm-and-sleep blend can reasonably reach for something with mood evidence behind it.

That is a defensible rationale. What makes it worth an article is that this particular ingredient brings something else with it, and the something else is the most consequential safety item on a great many labels that carry it.

What enzyme induction actually is

The liver takes most medicines apart using a family of enzymes, and one member of that family, cytochrome P450 3A4, does more of that work than any other.

Induction means making the body produce more of that enzyme. More enzyme means faster clearance, and faster clearance means lower blood levels of whatever the enzyme handles.

So the effect of this herb on a prescription medicine is usually to make it weaker. That is the opposite of the interaction people expect, and it is the reason it is so easily missed.

It also works in reverse

Induction takes time to build and time to wear off. Stopping the herb after weeks of taking it lets enzyme levels fall back, and blood levels of the medicine rise again. Somebody whose dose was adjusted while taking the herb can end up over-treated after stopping it, which is why both starting and stopping are worth mentioning to a prescriber.

What the interaction studies measured

A controlled study published in JAMA gave 300 mg three times daily for two weeks and measured drug metabolism directly. Alprazolam clearance roughly doubled.

A separate controlled study gave the same schedule alongside an oral contraceptive and measured reduced exposure to it, with breakthrough bleeding reported.

A survey of what has been reported clinically widens the list considerably: medicines that keep a transplanted organ in place, blood thinners, a number of antidepressants, some antiretrovirals. NCCIH’s own page summarises it for a general reader and is a reasonable thing to put in front of somebody who does not want to read a pharmacology review.

Findings from the published interaction studies. They describe the herb at a stated dose rather than any particular product.

Why this is the quiet kind of interaction

Most people picture a drug interaction as something dramatic: a reaction, a rash, a night in hospital. This is not that.

A medicine at a lower blood level does not announce itself. An antidepressant works a little less well. A transplant medicine protects a little less. A contraceptive fails.

None of those produces a symptom that points at a herbal capsule, and most of them produce no symptom at all until something has already happened. That is what makes this worth naming explicitly rather than covering with a general caution.

It is also why what this page asks of a reader is a sentence to speak rather than a caution to absorb. Describe the bottle and a pharmacy has nothing to work with. Give it the ingredient and the check takes ten seconds at a keyboard.

Not every preparation carries the same risk

This is the part that gets left out of most consumer writing about the herb, and it matters.

A 2020 review of the clinical relevance of these interactions sets out that the induction tracks hyperforin content. Hyperforin is one of the constituents of the plant, extracts vary widely in how much of it they carry, and low-hyperforin preparations carry far less interaction risk than standard ones.

So two products both listing St. John’s wort can present genuinely different risks, and the figure that separates them is a hyperforin percentage.

That figure is almost never on a consumer label. On a blend it is rarer still, and where the quantities themselves come with the bottle rather than with the artwork, both halves of the question are open at once: how much of the herb, and how much hyperforin in it.

For a reader the position is uncomfortable and simple. The same three words on a panel could describe a token quantity of a gentle extract or a full daily dose of a standard one, and from outside the factory there is no way to tell which.

What it is actually good at

It would be unfair to leave the impression that this is a bad ingredient. It is a well-studied one that happens to be in the wrong aisle.

A systematic review of St. John’s wort for major depressive disorder covers the evidence that made it one of the most widely used herbal products in the world. In several countries it is a licensed medicine rather than a supplement, which is itself a comment on how seriously the interaction profile is taken.

What it does not have is sleep evidence. There is no human trial giving St. John’s wort for insomnia, and its appearance on a sleep label is a formulation judgement rather than a result.

The conversation to have, and with whom

Four conversations, and the first one covers most of the risk on this page.

• Take the bottle, or a photograph of its back label, rather than describing it.
• Name the ingredient rather than the brand. Brand names mean nothing to an interaction checker.
• Mention it when a new medicine is started, not only when the supplement is.
• Mention it again when you stop, because the induction wears off over weeks.
• If you are told to avoid it, that is the answer, and there are twelve other ingredients on a label like this one.

Who should simply decide against it

Some people do not need a conversation, they need a decision, and it is worth being direct about who.

Anyone relying on a hormonal contraceptive. The interaction is documented, the failure mode is silent, and where the amount is unknown there is nothing to weigh against it.

Anyone on a medicine with a narrow margin between working and not working: an anticoagulant, a transplant medicine, certain antiretrovirals. The same reasoning, with more at stake.

Anyone pregnant, trying to conceive or nursing, for whom the whole category is a conversation rather than a purchase.

And anyone who simply does not want to think about it. A sleep supplement is an optional purchase, and an ingredient that requires a pharmacy conversation before the first capsule is a reasonable thing to decline. The suitability page on this website ends in a decision table with three rows that recommend not ordering, and this is one of them.

References